Literature DB >> 11122748

Small, dense, low-density lipoprotein and atherosclerosis.

H R Superko1.   

Abstract

Disorders of low-density lipoprotein (LDL) and high- density lipoprotein (HDL) subclass distribution are more common contributors to coronary artery disease (CAD) than is elevated low-density lipoprotein cholesterol (LDLC). Recent research has emphasized the importance of LDL and HDL subclass distribution in patient management and response to treatments. Laboratory determination of LDL and HDL subclass distribution involves analytic ultracentrifugation or polyacrylalmide gradient gel electrophoresis. If subclass distribution is to be used for patient management, research quality control and standards are necessary in order to assure that the patient's values accurately reflect the metabolic disorder. The importance of this topic for patient care has been recognized by the medical insurance industry. Investigations employing electron beam computed tomography in asymptomatic individuals has revealed that 50% with established CAD have normal lipids by National Cholesterol Education Program (NCEP) criteria. However, a large proportion of other metabolic contributors to CAD are not revealed by routine blood tests.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122748     DOI: 10.1007/s11883-000-0024-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  20 in total

1.  LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.

Authors:  C Skoglund-Andersson; R Tang; M G Bond; U de Faire; A Hamsten; F Karpe
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

2.  Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.

Authors:  H N Hodis; W J Mack; M Dunn; C Liu; C Liu; R H Selzer; R M Krauss
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

3.  Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.

Authors:  B D Miller; E L Alderman; W L Haskell; J M Fair; R M Krauss
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

4.  Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men.

Authors:  P T Williams; R M Krauss; K M Vranizan; P D Wood
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

5.  Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.

Authors:  H R Superko; P D Wood; R M Krauss
Journal:  Am J Med       Date:  1989-01-23       Impact factor: 4.965

6.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.

Authors:  A Zambon; J E Hokanson; B G Brown; J D Brunzell
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

7.  Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men.

Authors:  D M Dreon; H A Fernstrom; B Miller; R M Krauss
Journal:  FASEB J       Date:  1994-01       Impact factor: 5.191

8.  Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease.

Authors:  A D Guerci; L A Spadaro; K J Goodman; A Lledo-Perez; D Newstein; G Lerner; Y Arad
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

Review 9.  Did grandma give you heart disease? The new battle against coronary artery disease.

Authors:  H R Superko
Journal:  Am J Cardiol       Date:  1998-11-05       Impact factor: 2.778

10.  Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women.

Authors:  M A Austin; L Mykkänen; J Kuusisto; K L Edwards; C Nelson; S M Haffner; K Pyörälä; M Laakso
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  6 in total

Review 1.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

Review 2.  Mechanisms and Treatment of Dyslipidemia in Diabetes.

Authors:  Ehete Bahiru; Ruth Hsiao; Daniel Phillipson; Karol E Watson
Journal:  Curr Cardiol Rep       Date:  2021-03-02       Impact factor: 2.931

3.  Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials.

Authors:  John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

Review 4.  Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials.

Authors:  John A Farmer
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

Review 5.  Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart.

Authors:  Alicia D'Souza; Munir Hussain; Frank C Howarth; Niall M Woods; Keshore Bidasee; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2009-05-23       Impact factor: 3.396

Review 6.  Treatment of dyslipidemia in patients with type 2 diabetes.

Authors:  Krishnaswami Vijayaraghavan
Journal:  Lipids Health Dis       Date:  2010-12-20       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.